If a patient does not require treatment with loop diuretics, do they really have heart failure?
- PMID: 40038858
- DOI: 10.1002/ejhf.3628
If a patient does not require treatment with loop diuretics, do they really have heart failure?
References
-
- Cleland JG, Tavazzi L, Daubert JC, Tageldien A, Freemantle N. Cardiac resynchronization therapy: Are modern myths preventing appropriate use? J Am Coll Cardiol 2009;53:608–611. https://doi.org/10.1016/j.jacc.2008.10.040
-
- Cleland JGF. Nature and magnitude of the benefits of dapagliflozin and empagliflozin for heart failure. Circulation 2024;149:839–842. https://doi.org/10.1161/CIRCULATIONAHA.123.068089
-
- Chouairi F, Fudim M, Savarese G, Szabo B, Dahlstrom U, Hage C, et al. Utility of loop diuretics as a marker of risk in clinical trials of heart failure with preserved ejection fraction: Analysis from the Swedish Heart Failure Registry. Eur J Heart Fail 2025;27:972–978. https://doi.org/10.1002/ejhf.3578
-
- Cleland JGF, Pfeffer MA, Clark AL, Januzzi JL, McMurray JJV, Mueller C, et al. The struggle towards a universal definition of heart failure – how to proceed? Eur Heart J 2021;42:2331–2343. https://doi.org/10.1093/eurheartj/ehab082
-
- Pellicori P, Cleland JG, Zhang J, Kallvikbacka‐Bennett A, Urbinati A, Shah P, et al. Cardiac dysfunction, congestion and loop diuretics: Their relationship to prognosis in heart failure. Cardiovasc Drugs Ther 2016;30:599–609. https://doi.org/10.1007/s10557‐016‐6697‐7
Publication types
LinkOut - more resources
Full Text Sources